scholarly article | Q13442814 |
P2093 | author name string | B L Jensen | |
A E Lykkesfeldt | |||
J Skouv | |||
B K Lundholt | |||
P2860 | cites work | Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction | Q28131789 |
The human estrogen receptor has two independent nonacidic transcriptional activation functions | Q29617089 | ||
Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer. | Q34300189 | ||
Oestrogen receptor: a stable phenotype in breast cancer | Q36134377 | ||
Induction of estrogen independence of ZR-75-1 human breast cancer cells by epigenetic alterations | Q36677696 | ||
Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover | Q37599824 | ||
Tamoxifen in advanced breast cancer | Q39782157 | ||
36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO | Q40505449 | ||
Are breast tumours resistant to tamoxifen also resistant to pure antioestrogens? | Q40797410 | ||
Resistance of human breast-cancer cells to the pure steroidal anti-estrogen ICI 182,780 is not associated with a general loss of estrogen-receptor expression or lack of estrogen responsiveness | Q41083185 | ||
Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen | Q41160149 | ||
Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines | Q41198739 | ||
Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells | Q41291278 | ||
Human breast cancer cell lines resistant to pure anti-estrogens are sensitive to tamoxifen treatment | Q41345051 | ||
Differential expression of estrogen receptor mRNA splice variants in the tamoxifen resistant human breast cancer cell line, MCF-7/TAMR-1 compared to the parental MCF-7 cell line | Q41354892 | ||
Mechanisms of tamoxifen resistance in the treatment of advanced breast cancer | Q41463841 | ||
Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1. | Q41480629 | ||
The mechanism of ICI 164,384 antiestrogenicity involves rapid loss of estrogen receptor in uterine tissue | Q41661309 | ||
Expression of estrogen receptor and its messenger ribonucleic acid in the MCF-7 cell line: multiparametric analysis of its processing and regulation by estrogen | Q41714899 | ||
Hormonal regulation of estrogen receptor messenger ribonucleic acid in T47Dco and MCF-7 breast cancer cells | Q42505128 | ||
Effect of estrogen and antiestrogen on the human breast cancer cell line MCF-7 adapted to growth at low serum concentration | Q42822693 | ||
A potent specific pure antiestrogen with clinical potential | Q46965638 | ||
Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer. | Q54172521 | ||
Antiestrogen resistance: mechanisms by which breast cancer cells undermine the effectiveness of endocrine therapy. | Q54286503 | ||
Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer | Q59289357 | ||
Nuclear mechanisms of estrogen action. Effects of estradiol and anti-estrogens on estrogen receptors and nuclear receptor processing | Q67404696 | ||
Regulation of the estrogen receptor in MCF-7 cells by estradiol | Q68015751 | ||
Estrogenic and antiestrogenic regulation of the half-life of covalently labeled estrogen receptor in MCF-7 breast cancer cells | Q71114385 | ||
The value of estrogen and progesterone receptors in the treatment of breast cancer | Q71432010 | ||
Estradiol-induced down-regulation of estrogen receptor. Effect of various modulators of protein synthesis and expression | Q72326474 | ||
Selective inhibition of estrogen-regulated gene expression in vivo by the pure antiestrogen ICI 182,780 | Q73470551 | ||
Acquired estrogen independence and antiestrogen resistance in breast cancer: estrogen receptor driven phenotypes? | Q81066714 | ||
P4510 | describes a project that uses | MCF-7/182R-6 | Q54904343 |
P433 | issue | 3-4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell line | Q21014462 |
P304 | page(s) | 386-392 | |
P577 | publication date | 1999-02-01 | |
P1433 | published in | British Journal of Cancer | Q326309 |
P1476 | title | Differential regulation of specific genes in MCF-7 and the ICI 182780-resistant cell line MCF-7/182R-6. | |
P478 | volume | 79 |
Q37038692 | A candidate molecular signature associated with tamoxifen failure in primary breast cancer |
Q37393002 | Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant |
Q28359567 | Anti-oestrogen resistant human breast cancer cell lines are more sensitive towards treatment with the vitamin D analogue EB1089 than parent MCF-7 cells |
Q40823033 | Demonstration of estrogen receptors and of estrogen responsiveness in the HKT-1097 cell line derived from diethylstilbestrol-induced kidney tumors |
Q36620883 | Development and characterization of a tamoxifen-resistant breast carcinoma xenograft |
Q64120894 | Differential microRNA expression profiles determined by next-generation sequencing in three fulvestrant-resistant human breast cancer cell lines |
Q40649819 | Effect of antiestrogens and aromatase inhibitor on basal growth of the human breast cancer cell line MCF-7 in serum-free medium |
Q39756962 | Effects of nutrition relevant mixtures of phytoestrogens on steroidogenesis, aromatase, estrogen, and androgen activity |
Q40541435 | Estrogen responsiveness of IBEP-2, a new human cell line derived from breast carcinoma |
Q43704085 | Identification of two estrogen regulated genes associated with growth regulation of human breast cancer. |
Q54028727 | Increased expression of cytochrome p450 1A1 and 1B1 genes in anti-estrogen-resistant human breast cancer cell lines. |
Q43678719 | Insulin-like growth factor receptor levels are regulated by cell density and by long term estrogen deprivation in MCF7 human breast cancer cells |
Q35168124 | New cell culture model for aromatase inhibitor-resistant breast cancer shows sensitivity to fulvestrant treatment and cross-resistance between letrozole and exemestane |
Q43641338 | Novel cell lines established from a human myxoid malignant fibrous histiocytoma arising in the uterus |
Q30441001 | Pathways to tamoxifen resistance |
Q37169153 | Prostaglandin F2alpha elevates blood pressure and promotes atherosclerosis. |
Q37066053 | Tamoxifen resistance and epigenetic modifications in breast cancer cell lines |
Q31875534 | The control of progesterone receptor expression in MCF-7 breast cancer cells: effects of estradiol and sex hormone-binding globulin (SHBG). |
Q37328397 | The role of amphiregulin in exemestane-resistant breast cancer cells: evidence of an autocrine loop |
Q54904343 | MCF-7/182R-6 | described by source | P1343 |
Search more.